Under the Misuse of Drugs (Modification) Orders, 2018 and updated in 2019, HSC has provided an exemption for certain products from various prohibitions in law regarding the import, export, possession and supply of CBD products of a specified description.
CBD (Cannabidiol) is one of the 150+ naturally occurring Phytocannabinoids found in certain strains of hemp and in all cannabis plant strains.
CBD products now exempt are those meeting the following conditions:
- Have its ingredients clearly labelled
- Contain an aggregate of not more than 3% cannabinol or cannabinol derivatives relative to its CBN content, by weight, unless the CBN content is below 2.5% of the final product then the Cannibinol content is calculated on the whole product and must not exceed 0.1% of the whole product content.
- Not contain any other controlled drug
- Not contain any plant material visible to the naked eye
The requirement regarding the percentage of cannabinol (or derivative) must be confirmed by either the States Analyst or by an accredited laboratory.
This modification order, and the checks on importation carried out by the Guernsey Border Agency, ensures that the public can have confidence that CBD Oil products purchased in Guernsey meet the requirements of the Misuse of Drugs Law.
It must be stressed that this exemption does not extend to the commercial exportation of CBD products i.e. fulfillment, this requires HSC to grant a licence.
For further information on this please contact the Chief Pharmacist on tel +44 1481 725241